Impact of race on diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors
Published: 1 October 2020| Version 1 | DOI: 10.17632/m689r3v4r3.1
Contributors:
Leah Thompson , Catherina Pan, Michael Chang, Nira Krasnow, Steven Chen, Amy BlumDescription
Study flow diagram showing process of selecting patients receiving immune checkpoint inhibitors with confirmed cirAE diagnoses
Files
Categories
Flow Chart